Sobi launches enhanced corporate sustainability initiative
Swedish Orphan Biovitrum AB (publ) (Sobi™) announces today, on Rare Disease Day , the launch of an enhanced corporate sustainability programme with a strong connection to the company’s strategy of providing sustainable access to treatments for rare diseases. As part of the new sustainability strategy, Sobi has identified several focus areas that are important for both the stakeholder communities and Sobi’s business. Sobi’s stakeholders include the communities of patients and caregivers affected by rare diseases, the local